Market News, June 22, 2026

Monday June 22 pre-market is running on M&A, biotech catalysts, and low-float momentum. APGE is the headline, up 47% on a confirmed AbbVie acquisition. DFTX is up 40% ahead of a Phase 3 data presentation today. EHGO, the 1.21M float name that ran in mid-June on an AI partnership, is making another move this morning. And CRMT, the $3 debt-restructuring low-float, is squeezing again on its 6.69M float.

On the down side, CAST is giving back from its 168% run on June 18 and CRVO is continuing its fade. Both patterns were called in last week's watch lists. The full recaps are here:

Also in the background this week: MU is up 4.35% pre-market in a pre-earnings run. Micron reports Wednesday after close. The setup from the week preview posted Sunday is playing out in real time at the open.

Economic Calendar, Week of June 22, 2026

  • Monday, June 22: No major data. M&A and biotech catalyst tape.

  • Tuesday, June 23: FedEx (FDX) earnings after close.

  • Wednesday, June 24: May New Home Sales. Fed Bank Stress Test Results (impact: High). Micron Technology (MU) earnings after close.

  • Thursday, June 25: Q1 GDP Final Estimate (impact: High). May PCE Inflation (impact: High, economists expect 4.1% annual). May Durable Goods Orders.

Trade Recap

APGE, Apogee Therapeutics | +47.48% | Float: 55.65M

AbbVie confirmed an $11 billion all-cash acquisition of Apogee Therapeutics on June 22. The deal was agreed on June 18 via an Agreement and Plan of Merger. The offer price reflects a 60% premium to APGE's June 18 close of $90.38. Apogee develops treatments for atopic dermatitis and other inflammatory conditions. This is a straight M&A catalyst with a confirmed deal price. The move is not a rumor run, it is a locked tender premium.

DFTX, Definium Therapeutics | +39.95% | Float: 107.33M

Definium Therapeutics is discussing topline results from its Phase 3 EMERGE study today. The study targets major depressive disorder and generalized anxiety disorder with its lead candidate DT120 ODT. The company has three pivotal Phase 3 readouts approaching in 2026. This is a binary data event. The stock was at $32.42 going into last week, up 32% in anticipation, now up another 40% pre-market at $34.20. If the EMERGE topline results are positive, this name has room to extend. If results disappoint, the entire run reverses fast.

EHGO, Eshallgo Inc. | +47.12% | Float: 1.21M

EHGO is a China-based office supply and AI services company with a 1.21M share float. It ran from $1.32 to an intraday high above $7 on June 17 on an AI partnership announcement, then settled near $2.81 going into the weekend. The float is one of the smallest on the scanner this morning. This is a continuation off last week's catalyst with no new news confirmed pre-market. Names with 1.21M floats move on almost no volume. The intraday range on this type of float at this price is extreme in both directions.

CRMT, America's Car-Mart | +34.44% | Float: 6.69M

CRMT is a buy-here-pay-here used car retailer in active debt forbearance discussions with its lenders since early June. The stock was at $2.21 as of June 17, now at $3.24 pre-market, up 34% on a 6.69M float. This is a squeeze off a debt restructuring news pattern on a thin float. Any confirmed debt resolution or new credit agreement would be the catalyst to watch intraday. No confirmed resolution as of pre-market.

Premium Membership $10.99/mo

Discord Community $50/mo

Daily premarket watch lists for tickers I select. Educational only. No entries or exits. You execute your own trades.

Community membership fee for sharing trade ideas and Q&A. No financial decisions should be made based solely on ideas shared. Trade your own decisions. Not a trade alert or advisory service.

Subscribe to keep reading

This content is free, but you must be subscribed to StockTrader Weekly News to continue reading.

Already a subscriber?Sign in.Not now

Recommended for you